Page last updated: 2024-08-26

6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Leukemia L5178

6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) has been researched along with Leukemia L5178 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Magdon, E; Schröder, E1

Other Studies

1 other study(ies) available for 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Leukemia L5178

ArticleYear
[Studies on the action of MTDQ - 6,6'-methylene bis (2,2,4-trimethyl-1,2-dihydroquinoline) on the growth of murine mammary cancer, survival rate of V-79 cells and DNA biosynthesis of L5178 Y cells].
    Radiobiologia, radiotherapia, 1980, Volume: 21, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; DNA, Neoplasm; Drug Evaluation, Preclinical; Female; Leukemia L5178; Mammary Neoplasms, Experimental; Mice; Quinolines

1980